 | Up a level |
Mastall, Maximilian; Roth, Patrick; Bink, Andrea; Fischer Maranta, Angela; Läubli, Heinz; Hottinger, Andreas Felix; Hundsberger, Thomas; Migliorini, Denis; Ochsenbein, Adrian; Seystahl, Katharina; Imbach, Lukas; Hortobagyi, Tibor; Held, Leonhard; Weller, Michael; Wirsching, Hans-Georg (2024). A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC cancer, 24(1) BioMed Central 10.1186/s12885-023-11797-z
Hofer, Silvia; Keller, Kristina; Imbach, Lukas; Roelcke, Ulrich; Hutter, Gregor; Hundsberger, Thomas; Hertler, Caroline; Le Rhun, Emilie; Vasella, Flavio; Cordier, Dominik; Neidert, Marian; Hottinger, Andreas; Migliorini, Denis; Pflugshaupt, Tobias; Eggenberger, Noemi; Baumert, Brigitta; Läubli, Heinz; Gramatzki, Dorothee; Reinert, Michael; Pesce, Gianfranco; ... (2021). Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss medical weekly, 151, w20501. EMH Media 10.4414/smw.2021.20501
